Hull, United Kingdom

Neil Campbell Muir


Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 75(Granted Patents)


Location History:

  • Hull, HU8 7DS, GB (2006)
  • Welton, GB (2009)
  • Hull, GB (2004 - 2016)
  • Manchester, GB (2017)

Company Filing History:


Years Active: 2004-2017

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Neil Campbell Muir: Innovator in Pharmaceutical Formulations

Introduction

Neil Campbell Muir is a notable inventor based in Hull, GB. He has made significant contributions to the field of pharmaceutical formulations, holding a total of 8 patents. His work focuses on innovative compositions that enhance the effectiveness of various active agents.

Latest Patents

Among his latest patents is an oral composition comprising a cooling agent. This formulation includes an endothermic cooling agent selected from xylitol, sorbitol, mannitol, and erythritol, which has a heat of enthalpy between -10 cal/g and -100 cal/g. The cooling agent is present in the formulation at an amount less than 10% w/w. Another significant patent is a pharmaceutical formulation in the form of a tablet. This tablet includes a first portion with guaifenesin for immediate release and a second portion with a sustained release profile. The second drug can be an anti-tussive or a decongestant, and it may be in the form of a drug-resin complex.

Career Highlights

Neil has worked with Reckitt Benckiser (UK) Limited, where he applied his expertise in developing innovative pharmaceutical products. His career reflects a commitment to advancing the field of drug formulation and delivery.

Collaborations

Throughout his career, Neil has collaborated with notable individuals such as Malcolm Tom McKechnie and Stuart Michael Ruan Jones. These collaborations have contributed to the development of his innovative patents.

Conclusion

Neil Campbell Muir is a distinguished inventor whose work in pharmaceutical formulations has led to multiple patents. His innovative approaches continue to influence the industry and improve therapeutic outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…